United States  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Bioasis Announces Closing of Previously Disclosed Private Placement

Business Wire Tuesday, 21 May 2019
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (“Bioasis” or the “Company”) (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (the “BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced the close of its previousl
0
shares
ShareTweetSavePostSend
 

You Might Like


Other recent news in Press Releases

Triumvira Immunologics Announces Clearance of IND and CTA by U.S. FDA and HEALTH Canada for Its First TAC T-cell Therapeutic Product Candidate, TAC01-CD19PwC and Xero Extend Global Collaboration to Help Small BUSINESS Succeed
Global SOFTWARE Leaders Xero and Stripe Join Forces to Bring Seamless Payments to Millions of Small BusinessesBlonder Tongue Labs Brings In-Room WiFi to their Line of Hospitality Cable Modem PRODUCTS
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.